Russell NH, Thomas A, Hills RK, Thomas I, et al. Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial. J Clin Oncol 2025;43:694-704.
PMID: 39556780